Clinical trial
LTFU for All Cell and Gene Therapy Studies
NCT06194461
Study timeline
Study start (estimated)2025-09-17Date precision: day
Registry last updated2025-06-27
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Hepatocellular Carcinomaunresolved
Prostate Cancerunresolved
Interventions
Sponsors & collaborators
AstraZenecalead sponsor
Mapped research locations
SeoulSouth Korea3New YorkNew York, United States1HoustonTexas, United States1PhiladelphiaPennsylvania, United States1St LouisMissouri, United States1AtlantaGeorgia, United States1San FranciscoCalifornia, United States1PittsburghPennsylvania, United States1ColumbusOhio, United States1TampaFlorida, United States1PortlandOregon, United States1Washington D.C.District of Columbia, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT06194461 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.